| Reaction Details |
|---|
 | Report a problem with these data |
| Target | RAF proto-oncogene serine/threonine-protein kinase [306-648,Y340D,Y341D] |
|---|
| Ligand | BDBM210021 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Raf IC50 Assay Protocol |
|---|
| IC50 | <0.250±n/a nM |
|---|
| Citation |  Zhou, C; Wang, S; Zhang, G Fused tricyclic compounds as Raf kinase inhibitors US Patent US10576087 Publication Date 3/3/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| RAF proto-oncogene serine/threonine-protein kinase [306-648,Y340D,Y341D] |
|---|
| Name: | RAF proto-oncogene serine/threonine-protein kinase [306-648,Y340D,Y341D] |
|---|
| Synonyms: | C-Raf (Y340D/Y341D) | RAF | RAF1 | RAF1_HUMAN |
|---|
| Type: | n/a |
|---|
| Mol. Mass.: | 38958.87 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | PV3805, from Invitrogen |
|---|
| Residue: | 343 |
|---|
| Sequence: | SQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSDDWEIEASEVMLSTRIGSGSFGTVYK
GKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCE
GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIG
DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE
LPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS
IELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF
|
|
|
|---|
| BDBM210021 |
|---|
| n/a |
|---|
| Name | BDBM210021 |
|---|
| Synonyms: | US10576087, Compound 2.27 | US9273046, 2.27 | US9895376, Compound 2.27 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C24H18N4O4 |
|---|
| Mol. Mass. | 426.4241 |
|---|
| SMILES | Oc1ccc2nc([nH]c2c1)C1C2Oc3ccc(Oc4ccnc5NC(=O)CCc45)cc3C12 |
|---|
| Structure | 
|
|---|
Search and Browse
